Abivax S.A annual free cash flow
2021
2022
2023
2024
2025
Abivax S.A Free Cash Flow (FCF) History (ABVX)
Abivax S.A reported −€161.3M in free cash flow for fiscal 2025, a decrease of €6.6M from the previous fiscal year, with a free cash flow margin of −3528.91%.
View full Abivax S.A company overviewAbivax S.A free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −€161.3M | −€6.6M | — | −3528.91% |
| 2024 | 2024-12-31 | −€154.7M | −€57.3M | — | −1242.77% |
| 2023 | 2023-12-31 | −€97.4M | −€43.2M | — | −2107.66% |
| 2022 | 2022-12-31 | −€54.2M | −€9.1M | — | −1183.16% |
| 2021 | 2021-12-31 | −€45.1M | — | — | −377.02% |
Abivax S.A quarterly free cash flow
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −€23.3M | €10.3M | — | −5298.86% |
| Q3 2025 | 2025-09-30 | −€71.3M | −€35.6M | — | −3489.53% |
| Q2 2025 | 2025-06-30 | −€33.4M | €17.3M | — | −3052.06% |
| Q1 2025 | 2025-03-31 | −€33.3M | €1.4M | — | −3352.31% |
| Q4 2024 | 2024-12-31 | −€33.6M | — | — | −779.56% |
| Q3 2024 | 2024-09-30 | −€35.7M | — | — | −2695.92% |
| Q2 2024 | 2024-06-30 | −€50.6M | — | — | −899.88% |
| Q1 2024 | 2024-03-31 | −€34.8M | — | — | −2931.37% |
Abivax S.A free cash flow growth trends
Abivax S.A's latest reported quarter, Q4 2025, generated −€23.3M in free cash flow, an increase of €10.3M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Abivax S.A filings at SEC.gov ↗